SCHEMBL23819025

SCHEMBL23819025

COC(=O)[C@H](C)N[PH](=O)OC[C@@](C#N)(OC)[C@@H](OC(=O)[C@@H](C)OC)[C@@H](OC(=O)[C@@H](C)OC)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23819087 0.96 — —
SCHEMBL23818608 0.96 — —
SCHEMBL26332408 0.91 RIPK1 (0.30) —
SCHEMBL23818990 0.88 — —
SCHEMBL26333107 0.87 — —
SCHEMBL26333558 0.87 — —
SCHEMBL23818667 0.87 — —
SCHEMBL23819225 0.86 — —
SCHEMBL23819136 0.85 — —
SCHEMBL23819110 0.85 RIPK1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback